Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antibiotics
100%
Pseudomonas Aeruginosa Biofilm
100%
Engineered Peptide
100%
Biofilm Formation
80%
Biofilm
40%
Pseudomonas Aeruginosa (P. aeruginosa)
40%
17BIPHE2
40%
Early Treatment
20%
Combination Therapy
20%
Antibiofilm
20%
Bacterial Adhesion
20%
Monotherapy
20%
Peptide Concentration
20%
3D Structure
20%
Bacterial Growth
20%
Difficult-to-treat Infections
20%
Bacterial Inoculant
20%
Time Dependence
20%
Bacterial Killing
20%
Biofilm Growth
20%
Cationic Antimicrobial Peptides
20%
Human Cathelicidin LL-37
20%
In Vitro Biofilm Models
20%
Preformed Biofilms
20%
Antibiofilm Compounds
20%
Growth Time
20%
Database Screening
20%
Biofilm Disruption
20%
Biofilm Treatment
20%
Immunology and Microbiology
Peptides
100%
Biofilm
100%
Pseudomonas aeruginosa
100%
Inoculum
9%
Bacterium Adherence
9%
Bacterial Growth
9%
Cathelicidin
9%
Bactericidal Activity
9%
Cationic Antimicrobial Peptide
9%
Infection
9%
In Vitro
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Pseudomonas aeruginosa
100%
Infection
20%
Combination Therapy
20%
Monotherapy
20%
Antimicrobial Cationic Peptide
20%
Cathelicidin Antimicrobial Peptide LL 37
20%
Food Science
Bacterial Growth
100%
Cathelicidin
100%
Cationic Antimicrobial Peptide
100%